Compare Canopy Growth Corp (CGC) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs The Coca-Cola Co K — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while The Coca-Cola Co K trades at $83.27 (market cap $357.45B). The key difference: The Coca-Cola Co K is far larger — about 897.1× Canopy Growth Corp's market cap, and The Coca-Cola Co K pays a 2.55% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | KO | |
|---|---|---|
Market Cap | $398.46M | $357.45B |
Sector | Health | Consumer Staples |
52-Week High | $1.92 | $84.25 |
52-Week Low | $0.86 | $65.67 |
Enterprise Value | $337.90M | $387.52B |
Volume | — | 14,630,257 |
Dividend Yield | — | 2.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Coca-Cola (KO) trades at $84.25, up 0.91% on the day, with a bullish technical signal from moving averages and strong support at $84. The company reported consistent earnings beats in recent quarters, with Q1 2026 EPS of $0.86 beating expectations of $0.812. Fundamentals show robust profitability with a net income margin of 27.8% and ROE of 45.8%, while revenue grew to $47.94B in 2025. Recent news highlights institutional buying and stable demand trends ahead of Q2 earnings.
The outlook for KO is positive, supported by analyst consensus with a $89.75 price target and 60% buy ratings. Investment appeal lies in its dividend track record—64 consecutive years of increases—and steady cash flow. Key risks include regional demand divergence, high debt levels, and competitive pressures. The stock offers a balanced opportunity for income and growth investors, though macroeconomic headwinds warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
